|
1
|
Menon MP, Pittaluga S and Jaffe ES: The
histological and biological spectrum of diffuse large B-cell
lymphoma in the World Health Organization classification. Cancer J.
18:411–420. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pulvino M, Liang Y, Oleksyn D, DeRan M,
Van Pelt E, Shapiro J, Sanz I, Chen L and Zhao J: Inhibition of
proliferation and survival of diffuse large B-cell lymphoma cells
by a small-molecule inhibitor of the ubiquitin-conjugating enzyme
Ubc13-Uev1A. Blood. 120:1668–1677. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ramachandiran S, Adon A, Guo X, Wang Y,
Wang H, Chen Z, Kowalski J, Sunay UR, Young AN, Brown T, et al:
Chromosome instability in diffuse large B cell lymphomas is
suppressed by activation of the noncanonical NF-κB pathway. Int J
Cancer. 136:2341–2351. 2015. View Article : Google Scholar
|
|
4
|
Niu M, Shen Y, Xu X, Yao Y, Fu C, Yan Z,
Wu Q, Cao J, Sang W, Zeng L, et al: Piperlongumine selectively
suppresses ABC-DLBCL through inhibition of NF-κB p65 subunit
nuclear import. Biochem Biophys Res Commun. 462:326–331. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Staudt LM: Oncogenic activation of
NF-kappaB. Cold Spring Harb Perspect Biol. 2:a0001092010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang J, Grubor V, Love CL, Banerjee A,
Richards KL, Mieczkowski PA, Dunphy C, Choi W, Au WY, Srivastava G,
et al: Genetic heterogeneity of diffuse large B-cell lymphoma. Proc
Natl Acad Sci USA. 110:1398–1403. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao Q, Fu W, Jiang H, Du J, Zhang C, Xi
H, Zhou F, Li R and Hou J: Clinicopathological implications of
nuclear factor κB signal pathway activation in diffuse large B-cell
lymphoma. Hum Pathol. 46:524–531. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Afonina IS, Elton L, Carpentier I and
Beyaert R: MALT1 - a universal soldier: Multiple strategies to
ensure NF-κB activation and target gene expression. FEBS J.
282:3286–3297. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martinez-Climent JA: The origin and
targeting of mucosa-associated lymphoid tissue lymphomas. Curr Opin
Hematol. 21:309–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bavi P, Abubaker J, Al-Sanea N,
Abduljabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Uddin S, Siraj AK
and Al-Kuraya KS: Clinico-pathological significance of TNF
alpha-induced protein3 (TNFAIP3) in Middle Eastern colorectal
carcinoma. Clin Epigenetics. 2:417–418. 2011. View Article : Google Scholar
|
|
11
|
Honma K, Tsuzuki S, Nakagawa M, Tagawa H,
Nakamura S, Morishima Y and Seto M: TNFAIP3/A20 functions as a
novel tumor suppressor gene in several subtypes of non-Hodgkin
lymphomas. Blood. 114:2467–2475. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Paik JH, Go H, Nam SJ, Kim TM, Heo DS, Kim
CW and Jeon YK: Clinicopathologic implication of A20/TNFAIP3
deletion in diffuse large B-cell lymphoma: An analysis according to
immunohistochemical subgroups and rituximab treatment. Leuk
Lymphoma. 54:1934–1941. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Nakamura S and Matsumoto T: Helicobacter
pylori and gastric mucosa-associated lymphoid tissue lymphoma:
Recent progress in pathogenesis and management. World J
Gastroenterol. 19:8181–8187. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nocturne G, Boudaoud S, Miceli-Richard C,
Viengchareun S, Lazure T, Nititham J, Taylor KE, Ma A, Busato F,
Melki J, et al: Germline and somatic genetic variations of TNFAIP3
in lymphoma complicating primary Sjogren's syndrome. Blood.
122:4068–4076. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fontan L and Melnick A: Targeting
lymphomas through MALT1 inhibition. Oncotarget. 3:1493–1494. 2012.
View Article : Google Scholar
|
|
16
|
McAllister-Lucas LM, Baens M and Lucas PC:
MALT1 protease: A new therapeutic target in B lymphoma and beyond?
Clin Cancer Res. 17:6623–6631. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He C, Liu Z, Ji J and Zhu H: Prognostic
value of survivin in patients with non-Hodgkin's lymphoma: A
meta-analysis. Int J Clin Exp Med. 8:5847–5854. 2015.PubMed/NCBI
|
|
18
|
Sun L, Zhao Y, Shi H, Ma C and Wei L:
LMP-1 induces survivin expression to inhibit cell apoptosis through
the NF-κB and PI3K/Akt signaling pathways in nasal NK/T-cell
lymphoma. Oncol Rep. 33:2253–2260. 2015.PubMed/NCBI
|
|
19
|
Abate D, Saldan A, Forner G, Tinto D,
Bianchin A and Palù G: Optimization of interferon gamma ELISPOT
assay to detect human cytomegalovirus specific T-cell responses in
solid organ transplants. J Virol Methods. 196:157–162. 2014.
View Article : Google Scholar
|
|
20
|
Coornaert B, Baens M, Heyninck K, Bekaert
T, Haegman M, Staal J, Sun L, Chen ZJ, Marynen P and Beyaert R: T
cell antigen receptor stimulation induces MALT1
paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat
Immunol. 9:263–271. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Debernardis D, Stanzione S, Ottoboni C,
Clerico L, Mancuso T, Parodi S and Russo P: Endogenous tumor
necrosis factor enhances topoisomerase II inhibitors activity in
human ovarian cancer cell lines. J Pharmacol Exp Ther. 279:84–90.
1996.PubMed/NCBI
|
|
22
|
Zelenetz AD: Guidelines for NHL: Updates
to the management of diffuse large B-cell lymphoma and new
guidelines for primary cutaneous CD30+ T-cell
lymphoproliferative disorders and T-cell large granular lymphocytic
leukemia. J Natl Compr Canc Netw. 12(Suppl 5): 797–800.
2014.PubMed/NCBI
|
|
23
|
Carbone A, Gloghini A, Kwong YL and Younes
A: Diffuse large B cell lymphoma: Using pathologic and molecular
biomarkers to define subgroups for novel therapy. Ann Hematol.
93:1263–1277. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Busca A, Saxena M and Kumar A: Critical
role for antiapoptotic Bcl-xL and Mcl-1 in human macrophage
survival and cellular IAP1/2 (cIAP1/2) in resistance to
HIV-Vpr-induced apoptosis. J Biol Chem. 287:15118–15133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fritzenwanger M, Jung C, Franz M, Foerster
M and Figulla HR: Immunomodulatory effects of cardiotrophin-1 on in
vitro cytokine production of monocytes and CD4+
T-lymphocytes. Indian J Med Res. 136:471–476. 2012.PubMed/NCBI
|
|
26
|
Yee J, White RE, Anderton E and Allday MJ:
Latent Epstein-Barr virus can inhibit apoptosis in B cells by
blocking the induction of NOXA expression. PLoS One. 6:e285062011.
View Article : Google Scholar : PubMed/NCBI
|
